BlackRock’s Natural Health Trends NHTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$169K Sell
95,588
-20,546
-18% -$53.9K ﹤0.01% 4865
2026
Q1
$324K Buy
116,134
+795
+0.7% +$2.66K ﹤0.01% 4633
2025
Q4
$356K Buy
115,339
+756
+0.7% +$2.74K ﹤0.01% 4576
2025
Q3
$513K Buy
114,583
+504
+0.4% +$2.29K ﹤0.01% 4450
2025
Q2
$494K Sell
114,079
-2,016
-2% -$9.67K ﹤0.01% 4442
2025
Q1
$587K Sell
116,095
-378
-0.3% -$1.88K ﹤0.01% 4357
2024
Q4
$538K Buy
116,473
+126
+0.1% +$684 ﹤0.01% 4395
2024
Q3
$692K Buy
116,347
+756
+0.7% +$5.18K ﹤0.01% 4257
2024
Q2
$821K Buy
115,591
+2,185
+2% +$15K ﹤0.01% 4224
2024
Q1
$760K Sell
113,406
-2,068
-2% -$12.9K ﹤0.01% 4277
2023
Q4
$677K Sell
115,474
-218
-0.2% -$1.2K ﹤0.01% 4352
2023
Q3
$613K Sell
115,692
-763
-0.7% -$4.15K ﹤0.01% 4366
2023
Q2
$644K Buy
116,455
+3,510
+3% +$19.2K ﹤0.01% 4418
2023
Q1
$558K Buy
112,945
+522
+0.5% +$2.58K ﹤0.01% 4507
2022
Q4
$386K Buy
112,423
+348
+0.3% +$1.32K ﹤0.01% 4679
2022
Q3
$412K Sell
112,075
-9,883
-8% -$49.8K ﹤0.01% 4780
2022
Q2
$654K Sell
121,958
-1,486
-1% -$9.87K ﹤0.01% 4684
2022
Q1
$874K Sell
123,444
-1,150
-0.9% -$8.37K ﹤0.01% 4713
2021
Q4
$842K Buy
124,594
+1,307
+1% +$9.36K ﹤0.01% 4724
2021
Q3
$884K Buy
123,287
+14,829
+14% +$103K ﹤0.01% 4591
2021
Q2
$758K Sell
108,458
-38,358
-26% -$277K ﹤0.01% 4591
2021
Q1
$991K Sell
146,816
-17,376
-11% -$111K ﹤0.01% 4503
2020
Q4
$817K Sell
164,192
-46,993
-22% -$261K ﹤0.01% 4262
2020
Q3
$1.19M Sell
211,185
-6,382
-3% -$36.5K ﹤0.01% 4067
2020
Q2
$1.25M Sell
217,567
-2,844
-1% -$14.7K ﹤0.01% 3988
2020
Q1
$725K Sell
220,411
-45,530
-17% -$184K ﹤0.01% 3968
2019
Q4
$1.43M Sell
265,941
-32,596
-11% -$209K ﹤0.01% 3892
2019
Q3
$2.12M Sell
298,537
-87,871
-23% -$644K ﹤0.01% 3730
2019
Q2
$3.11M Sell
386,408
-338,240
-47% -$3.54M ﹤0.01% 3652
2019
Q1
$9.39M Buy
724,648
+169,008
+30% +$2.52M ﹤0.01% 3148
2018
Q4
$10.3M Buy
555,640
+33,341
+6% +$733K ﹤0.01% 3070
2018
Q3
$12.2M Sell
522,299
-12,949
-2% -$317K ﹤0.01% 3140
2018
Q2
$13.4M Buy
535,248
+20,386
+4% +$426K ﹤0.01% 3092
2018
Q1
$9.79M Buy
514,862
+8,524
+2% +$144K ﹤0.01% 3139
2017
Q4
$7.69M Sell
506,338
-51,499
-9% -$971K ﹤0.01% 3272
2017
Q3
$13.3M Buy
557,837
+11,541
+2% +$263K ﹤0.01% 3009
2017
Q2
$15.2M Buy
546,296
+18,785
+4% +$537K ﹤0.01% 2935
2017
Q1
$15.2M Buy
527,511
+526,906
+87,092% +$14.2M ﹤0.01% 2915
2016
Q4
$15K Sell
605
-531
-47% -$13.4K ﹤0.01% 3314
2016
Q3
$32K Buy
1,136
+104
+10% +$3.22K ﹤0.01% 3146
2016
Q2
$29K Buy
1,032
+561
+119% +$18.3K ﹤0.01% 3152
2016
Q1
$16K Buy
471
+87
+23% +$2.36K ﹤0.01% 2953
2015
Q4
$13K Buy
384
+200
+109% +$8.8K ﹤0.01% 2766
2015
Q3
$6K Hold
184
﹤0.01% 2945
2015
Q2
$8K Buy
+184
New +$5.45K ﹤0.01% 2925

Other funds holding NHTC

BlackRock's NHTC Position: Q2 2026 in Review

BlackRock reduced its Natural Health Trends (NHTC) stake by 18% in Q2 2026, selling an estimated $53.9K and leaving 95,588 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #4865.

BlackRock first reported a position in NHTC in Q2 2015 and has held it in 45 quarters since. The position peaked at $15.2M in Q1 2017. 22 funds tracked by Wall St. Rank hold NHTC as of Q2 2026.

  • BlackRock held 95,588 shares of Natural Health Trends worth $169K as of Q2 2026.
  • BlackRock sold 20,546 Natural Health Trends shares in Q2 2026, an estimated $53.9K.
  • Natural Health Trends made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4865 holding.
  • BlackRock first reported a position in Natural Health Trends in Q2 2015 and has held it in 45 quarters since.
  • BlackRock's Natural Health Trends position peaked at $15.2M in Q1 2017.
  • 22 funds tracked by Wall St. Rank held Natural Health Trends as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.